本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ligand Pharmaceuticals Inc.

311.13
+9.323.09%
成交量:17.32万
成交额:5,322.03万
市值:62.03亿
市盈率:32.04
高:311.86
开:302.50
低:300.00
收:301.81
52周最高:326.63
52周最低:175.89
股本:1,993.56万
流通股本:1,935.39万
量比:0.76
换手率:0.89%
股息:- -
股息率:- -
每股收益(TTM):9.71
每股收益(LYR):6.13
净资产收益率:21.96%
总资产收益率:3.99%
市净率:6.41
市盈率(LYR):50.76

数据加载中...

2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/19

重要事件披露

Form 8-K - Current report
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/01

重要事件披露

Form 8-K - Current report